The Amyotrophic Lateral Sclerosis Market Demands of 2026 are being set by an increasingly vocal and well-informed patient community that is no longer satisfied with symptomatic relief alone. There is an urgent, massive demand for disease-modifying therapies (DMTs) that can move beyond merely slowing functional decline to actually halting or reversing motor neuron death. This shift has forced...